Andrographis
Andrographis paniculata · Andrographolide · Kalmegh
Snapshot
| Indications | Contraindications |
|---|---|
Andrographis (Andrographis paniculata, Kalmegh) is a bitter Asian herb whose andrographolides act through anti-inflammatory and immune-modulating effects6. It is used mainly for cough and sore throat in acute respiratory tract infections1. It is also used in ulcerative colitis, knee osteoarthritis pain, progressive multiple sclerosis, and coronavirus disease 2019 (COVID-19).
Randomized trials in respiratory infection show improved cough and sore throat against placebo, though trial quality was poor1. Pooled ulcerative colitis trials showed no significant response over placebo, while one placebo-controlled trial found less knee osteoarthritis pain. A 2022 open-label trial in Indonesian malaria patients reported high treatment efficacy without a control group7. Of 510 products listing andrographis, the sampled forms were capsules and liquids; see Form comparison.
Per Memorial Sloan Kettering, andrographis inhibits a liver enzyme that metabolizes aminophylline, raising that medication's side-effect risk, and its antioxidant effects may interfere with chemotherapy6. Per the same source, patients taking anticoagulants or antiplatelets are asked to consult their treating physician6.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
56 sources, 44 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis.pubmed.ncbi.nlm.nih.govHu, Wu, Logue et al. · PloS one · 2017 · Pubmed
- 2Herbal Medicine for Cough: a Systematic Review and Meta-Analysis.pubmed.ncbi.nlm.nih.govWagner, Cramer, Klose et al. · Forschende Komplementarmedizin (2006) · 2015 · Pubmed
- 3A double-blind, randomized, placebo-controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis.pubmed.ncbi.nlm.nih.govHancke, Srivastav, Cáceres et al. · Phytotherapy research : PTR · 2019 · Pubmed
- 4Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.pubmed.ncbi.nlm.nih.govCiampi, Uribe-San-Martin, Cárcamo et al. · BMC neurology · 2020 · Pubmed
- 5Health Canadahealth-products.canada.caLabel statements and adult daily amounts Health Canada authorized on licensed natural health products with this ingredient alone, from the Licensed Natural Health Products Database. Contains information licensed under the Open Government Licence – Canada
- 6MSKCCmskcc.orgMemorial Sloan Kettering — About Herbs, Botanicals & Other Products
- 7Open Clinical Trial of Sambiloto (Andrographis paniculata) Ethanolic Extract Capsules in Treatment of Malaria Patients in Batubara District, Indonesia.pubmed.ncbi.nlm.nih.govMakmur, Siregar, Siregar et al. · Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022 · Pubmed